From authoring through to submission, many Life Sciences companies struggle with maintaining a smooth and intuitive labelling process. Unconsolidated files and formats make it difficult for companies to track down and piece together relevant information, ever increasing the risk of error in end-results. And although there are many significant overlaps between the labelling process and other core RIM processes, why is it that we haven’t yet incorporated the Global Labelling Process into End-to-End RIM?
Join us for this webinar where Mark Willoughby, head of Life Sciences at Generis, will offer expert insight into overcoming the challenges of a disconnected Global Labelling landscape. See why the digitalisation of the labelling process as part of the end-to-end RIM process is so crucial.
Webinar Objectives:
Reserve your spot today to discover how to manage your global labelling as part of your end to end RIM process.
Note : This webinar is from Mark's presentation at the GPRAS conference, it will cover the global labelling use case and will NOT include a demo of the CARA Life Sciences Platform.